Biolin Scientific AB applies for delisting and convenes an extraordinary general meeting
At the request of Ratos AB (publ), the board of Biolin Scientific AB has today resolved to apply for delisting of the company’s shares that are listed on NASDAQ OMX Stockholm. At the request of Ratos, the board of Biolin Scientific has also resolved to convene an extraordinary general meeting to be held on February 17, 2011 for the purposes of electing a new board.
Following completion of Ratos public offer to the shareholders of Biolin Scientific, Ratos controls approximately 95 percent of the capital and the votes in Biolin Scientific. Ratos has also announced its intention to request compulsory redemtion of the Biolin Scientific shares that are not held by Ratos. The last day of trading in the company’s shares on NASDAQ OMX will be announced as soon as the company has received confirmation from NASDAQ OMX.
The Board of Biolin Scientific AB (publ)
For further information, please contact
Arne Bernroth, Chairman of the Board, Biolin Scientific
+46 (0)70 684 71 40